Serrapeptase
Serrapeptase, licence 80104185: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Activ Serrapeptase, Activ Serrapeptase 120,000, Activ Serratiopeptase, Activ Serratiopeptase 120,000, Inno-Serrapeptase, Inno-Serrapeptase 120,000, Inno-Serratiopeptase, Inno-Serratiopeptase 120,000, Serrapeptase 120,000, Serratiopeptase, Serratiopeptase 120,000
- Licence holder
- Innovite
- NPN or DIN-HM
- 80104185
- Status
- Inactive licence
- Licence date
- 11 September 2020
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Serrapeptase Source : Serratia marcescens E-15 - Cellule Entiière | 120000.0 SPU | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Stéarate de magnésium, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18.0 Année(s) | 1.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps reduce and/or relieve postoperative cheek swelling and/or pain after dental surgery. Helps to reduce (symptoms such as) pain, quantity of secretion, inability to perceive smell and stuffy nose from ear, nose and/or throat infections. Mucolytic enzyme that helps break down mucous. Mucolytic enzyme that helps break down mucous to reduce (symptoms such as) pain, quantity of secretion, inability to perceive smell and stuffy nose from ear, nose and/or throat infections. Proteolytic enzyme. Proteolytic enzyme that helps reduce and/or relieve postoperative cheek swelling and/or pain after dental surgery.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80104185
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Has the product changed? Photograph the packaging.